Exhibit 99.2

CRANE CO.

Income Statement Data

(in thousands, except per share data)

	Three Months Ended September 30,						Nine Months Ended September 30,
	2006			2005			2006			2005
Net Sales:
Aerospace & Electronics	$	142,982		$	141,722		$	429,860		$	409,243
Engineered Materials		71,636			75,558			239,931			235,550
Merchandising Systems		73,384			40,610			179,566			130,050
Fluid Handling		256,249			244,036			755,445			718,504
Controls		23,387			20,413			70,637			61,896
Intersegment Elimination		66			(108	)		(202	)		(331	)
Total Net Sales	$	567,704		$	522,231		$	1,675,237		$	1,554,912
Operating Profit:
Aerospace & Electronics	$	25,272		$	26,461		$	73,919		$	60,679
Engineered Materials		9,661			15,691			38,551			50,835
Merchandising Systems		8,887			3,529			17,101			11,362
Fluid Handling		29,404			21,131			83,780			53,588
Controls		2,112			1,711			7,664			5,287
Corporate		(4,173	)		(6,764	)		(26,546	)		(23,244	)
Total Operating Profit		71,163			61,759			194,469			158,507
Interest Income		552			503			2,163			1,004
Interest Expense		(5,244	)		(5,564	)		(16,268	)		(17,025	)
Miscellaneous- Net		1,461			778			7,143			2,844
Income Before Income Taxes		67,932			57,476			187,507			145,330
Provision for Income Taxes		21,889			17,434			59,602			44,616
Net Income	$	46,043		$	40,042		$	127,905		$	100,714
Share Data:
Net Income per Diluted Share	$	0.74		$	0.66		$	2.06		$	1.67
Average Diluted Shares Outstanding		62,226			60,490			62,192			60,229
Average Basic Shares Outstanding		61,110			59,936			60,941			59,676
Supplemental Data:
Cost of Sales	$	378,054		$	356,058		$	1,125,978		$	1,071,033
Selling, General & Administrative		118,487			104,414			354,790			325,372
Depreciation and Amortization *		12,259			11,666			39,056			36,509
Stock Compensation Expense		3,169			1,579			11,288			6,452

* Amount included within cost of sales and selling, general & administrative costs.

CRANE CO.

Condensed Balance Sheets

(in thousands)

	September 30, 2006		December 31, 2005
ASSETS
Current Assets
Cash and Cash Equivalents	$	99,077	$	180,392
Accounts Receivable		342,865		289,521
Inventories		301,963		272,354
Other Current Assets		51,467		56,128
Total Current Assets		795,372		798,395
Property, Plant and Equipment		267,236		263,791
Insurance Receivable - Asbestos		214,626		224,600
Other Assets		341,698		284,345
Goodwill		712,377		568,355
Total Assets	$	2,331,309	$	2,139,486
LIABILITIES AND SHAREHOLDERS’ EQUITY
Current Liabilities
Notes Payable and Current Maturities of Long-Term Debt	$	315	$	254
Accounts Payable		155,557		149,647
Current Asbestos Liability		55,000		55,000
Accrued Liabilities		186,024		174,366
Income Taxes		28,984		19,322
Total Current Liabilities		425,880		398,589
Long-Term Debt		366,094		293,248
Deferred Tax Liability		70,417		71,406
Long-Term Asbestos Liability		486,899		526,830
Other Liabilities		88,315		96,119
Shareholders’ Equity		893,704		753,294
Total Liabilities and Shareholders’ Equity	$	2,331,309	$	2,139,486

CRANE CO.

Condensed Statements of Cash Flows

(in thousands)

	Three Months Ended September 30,						Nine Months Ended September 30,
	2006			2005			2006			2005
Operating Activities:
Net income	$	46,043		$	40,042		$	127,905		$	100,714
Income from joint venture		(1,306	)		(1,894	)		(4,525	)		(4,476	)
Gain on divestitures		(664	)		—			(8,931	)		—
Depreciation and amortization		12,259			11,666			39,056			36,509
Stock-based compensation expense		3,169			1,579			11,288			6,452
Cash (used for) provided by operating working capital		(1,469	)		9,573			(35,617	)		(35,063	)
Other		(1,501	)		11,532			3,697			14,665
Subtotal		56,531			72,498			132,873			118,801
Asbestos related payments, net of insurance recoveries		(20,877	)		(5,298	)		(29,957	)		(24,556	)
Refund associated with terminated Master Settlement Agreement		—			—			—			9,925
Total provided by operating activities		35,654			67,200			102,916			104,170
Investing Activities:
Capital expenditures		(5,311	)		(6,259	)		(22,312	)		(17,634	)
Proceeds from disposition of capital assets		463			188			3,317			1,569
Proceeds from divestitures		208			—			26,088			—
Payment for acquisition, net of cash acquired		(85,669	)		(7,157	)		(234,734	)		(7,157	)
Total used for investing activities		(90,309	)		(13,228	)		(227,641	)		(23,222	)
Financing Activities:
Dividends paid		(9,173	)		(7,509	)		(24,465	)		(19,429	)
Common shares acquired on the open market		(12,500	)		—			(37,499	)		—
Stock options exercised - net of shares reacquired		1,963			8,758			20,606			10,634
Excess tax benefit from stock-based compensation		800			—			7,575			—
Issuance of Debt		71,700			—			71,700			—
Repayment of debt, net		(79	)		1,009			(355	)		(3,416	)
Total provided by (used for) financing activities		52,711			2,258			37,562			(12,211	)
Effect of exchange rate on cash and cash equivalents		857			(2,250	)		5,848			(5,860	)
(Decrease) increase in cash and cash equivalents		(1,087	)		53,980			(81,315	)		62,877
Cash and cash equivalents at beginning of period		100,164			59,624			180,392			50,727
Cash and cash equivalents at end of period	$	99,077		$	113,604		$	99,077		$	113,604

CRANE CO.

Order Backlog

(in thousands)

	September 30, 2006		June 30, 2006		March 31, 2006		December 31, 2005		September 30, 2005
Aerospace & Electronics	$	380,224	$	380,514	$	364,539	$	365,010	$	366,109
Engineered Materials		13,162		18,617		16,972		17,241		20,673
Merchandising Systems		18,637		15,190		14,838		9,183		8,362
Fluid Handling		209,671		204,180		205,741		188,832		194,436
Controls		17,259		18,385		19,480		16,864		15,182
Total Backlog	$	638,953	$	636,886	$	621,570	$	597,130	$	604,762

CRANE CO.

Non-GAAP Financial Measures

(in thousands)

	September 30, 2006			December 31, 2005
BALANCE SHEET ITEMS
Notes Payable and Current Maturities of Long-Term Debt	$	315		$	254
Long-Term Debt		366,094			293,248
Total Debt		366,409			293,502
Less Cash and Cash Equivalents		(99,077	)		(180,392	)
Net Debt		267,332			113,110
Shareholders’ Equity		893,704			753,294
Total Capitalization	$	1,161,036		$	866,404
Percentage of Net Debt to Total Capitalization		23.0	%		13.1	%

	Three Months Ended September 30,						Nine Months Ended September 30,						Year Ended December 31,
	2006			2005			2006			2005			2006		2005
													(Estimated)
CASH FLOW ITEMS
Cash Provided from Operating Activities before Asbestos - Related Payments	$	56,531		$	72,498		$	132,873		$	118,801		$	245,000 – $260,000	$	216,958
Asbestos Related Payments, Net of Insurance Recoveries *		(20,877	)		(5,298	)		(29,957	)		(24,556	)		(45,000)		(45,338	)
Refund Associated with Terminated
Master Settlement Agreement		—			—			—			9,925			—		9,925
Cash Provided from Operating Activities		35,654			67,200			102,916			104,170		$	200,000 – $215,000		181,545
Less: Capital Expenditures		(5,311	)		(6,259	)		(22,312	)		(17,634	)		(30,000)		(27,164	)
Free Cash Flow	$	30,343		$	60,941		$	80,604		$	86,536		$	170,000 – $185,000	$	154,381

* Includes certain legal fees and expenses relating to the terminated Master Settlement Agreement amounting to $5.1 million for the full year of 2005, $4.5 million in the first nine months of 2005 and $.4 million in the third quarter of 2005.

Certain non-GAAP measures have been provided to facilitate comparison with the prior year.

Free cash flow provides supplemental information to assist management and investors in analyzing the Company’s ability to generate positive cash flow. Free cash flow is considered a measure of cash generation and should be considered in addition to, but not as a substitute for, other measures reported in accordance with generally accepted accounting principles and may be inconsistent with similar measures presented by other companies.